以每结肠镜检查腺瘤数和每阳性参与者腺瘤数作为筛查结肠镜新质量参数的评价
该研究基于奥地利筛查结肠镜质量认证数据库,纳入202名内镜医师实施的44,142例结肠镜检查,评估每阳性参与者腺瘤数(APP)和每结肠镜检查腺瘤数(APC)作为新质量参数。结果显示APC与腺瘤检出率(ADR)强相关(r=0.94),未提供ADR之外的信息;APP与所有其他参数相关性较弱。
要点
- APC与ADR强相关(r=0.94),未提供ADR之外的额外信息。
- APP与ADR(r=0.36)和进展期ADR(r=0.19)相关性较弱。
- 在ADR≥25%的内镜医师中,7名(10.3%)APP处于最低四分位,而无人APC处于最低四分位。
核心结论
- APC未揭示ADR之外的额外信息,因此无需以APC替代或补充ADR。
- APP可识别出尽管ADR可接受但每次操作发现腺瘤较少的内镜医师,但鉴于这些医师的进展期ADR仍较高,该额外信息对充分的结直肠癌预防可能不重要。
研究设计与样本
- 研究数据来自奥地利筛查结肠镜质量认证数据库的结肠镜检查记录,共纳入202名内镜医师实施的44,142例结肠镜检查。
- 采用Spearman相关分析比较ADR、APC、APP与进展期ADR,并使用t检验比较外科医师与内科医师之间、私人诊所与医院之间的参数差异。
主要发现
- APC与ADR强相关(r=0.94;P<.01),两者与进展期ADR的相关性相似(ADR:r=0.47;P<0.01,APC:r=0.46;P<.01)。
- APP与所有其他参数的相关性较弱(ADR:r=0.36;P<.01;进展期ADR:r=0.19;P<.01)。
- 私人诊所与医院在ADR、APP或APC方面无差异。
- 在ADR≥25%的内镜医师中,7名(10.3%)的APP处于最低四分位,而没有内镜医师的APC处于最低四分位。
临床怎么用
- 原文结论认为无需以APC替代或补充ADR。
- 作者指出APP虽可识别每次操作发现腺瘤较少的内镜医师,但该额外信息对充分的结直肠癌预防可能不重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The primary aim of this study was to evaluate adenomas per positive participant (APP) and adenomas per colonoscopy (APC) as new quality parameters in screening colonoscopy. Furthermore, we wanted to assess whether these parameters differ depending on the setting or profession. METHODS: Colonoscopy records were obtained from the database of the Austrian certificate of quality for screening colonoscopy. The Spearman correlation was calculated to compare the adenoma detection rate (ADR), APC, APP, and advanced ADR. The parameters were compared between surgeons and internists and between private practices and hospitals by using the t test. RESULTS: A total of 44,142 colonoscopies performed by 202 endoscopists were included. APC showed a strong correlation with ADR (r = 0.94; P < .01), and both showed a similar correlation with the advanced ADR (ADR: r = 0.47; P < 0.01, APC: r = 0.46; P < .01). APP showed weaker correlations compared with all other parameters (ADR: r = 0.36; P < .01; advanced ADR: r = 0.19; P < .01). Private practices did not differ in ADR, APP or APC from hospitals. Among endoscopists with ADRs of ≥25%, 7 (10.3%) had an APP in the lowest quartile, whereas no endoscopists had an APC in the lowest quartile. CONCLUSIONS: APC did not reveal additional information to ADR, and thus there is no need to use it instead of or additionally to ADR. Although the APP identifies endoscopists who find few adenomas per procedure despite acceptable ADRs, this additional information might not be important in regard to sufficient colorectal cancer prevention, because these endoscopists still had high advanced ADRs.
引用
- Gessl I, Waldmann E, Penz D, et al. Evaluation of adenomas per colonoscopy and adenomas per positive participant as new quality parameters in screening colonoscopy. Gastrointest Endosc. 2018. PMID: 30138613. doi:10.1016/j.gie.2018.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。